Ways of using make-up in right direction

Make-up is not the easiest process. Sometimes, it creates side effects also. If you use make-up properly, even the smallest eyes can be made to look large and expressive. Your thinnest lips can take a shape of an enticing pout.

You can show each and every facial expression that can be accentuated with a touch of make-up. In India, skin has forever been considered to be better than Caucasian skin. There is a thought of not using many make-up products. But in spite of that, the recent trend is now fast changing.

Before using any types of make-up on your face or skin, you should try it out on the underside of the elbow for allergies test.

In the recent times, from natural ingredients and this innovation completely removes the risk of skin problems arising from various chemical ingredients that were used earlier.

Despite it, you should keep in your mind that your skin’s capacity to tolerate certain products also depends on the season. Proper make-up removal is also another aspect of skin care. For the eyes, an oil-based eye make-up remover should be used.

About the permanent make-up, Dr. Jamuna Pai who is a renowned cosmetic physician says, “Known as micro pigmentation, in this process coloured pigments of mineral or natural origin are deposited on the uppermost layer of the skin called the epidermis. This is done with the help of disposable fine needles for the purpose of enhancing and contouring facial features.”

Further he reveals, “The number of people opting for this procedure is increasing with every passing day. It’s not just a relief from the everyday beauty ritual, but it also provides quick, easy and risk free make-up solutions. I do a minimum of 5-7 permanent eyebrows in a day.” The statement had been quoted by TOI, an online news portal.

However, in the recent time it is found that the normal skin can become drier from creams. The best way of using make-up in right direction is depended on the choosing right products to avoid any damage to your skin. In this way, you can take a view of anti-wrinkle cream to enhance internal beauty of face.

Reliance Life is to Launch Biosimilar Drug in Europe

Recently, the Mukesh Ambani-owned Reliance Life Sciences announced to launch its biosimilar drug to stimulate red blood cell production in Europe within a year. However, it has completed all required testing.

About the launch ET writes, “Unlike the pharmaceutical market that is flooded with generic versions of drugs, the biosimilar market, or market for generic versions of biological medicines, is relatively untapped. The global market for biosimilars is estimated at over $19 billion, and like all new things, the industry expects to make significant profits in the initial years.”

Further the news portal writes, “In the recently-passed US Health Bill the data exclusivity period for biological drugs was extended to 12 years from seven earlier, which is seen as detrimental to development of biosimilars. Countries are sceptical to allow biosimilars because they contain living active ingredients and are relatively new, so regulators have less experience in testing and dealing with them.

While Europe has a policy that approves of biosimilars, Indian companies have found it hard to crack the code. Dr Reddy’s has been in talks with regulators to launch a biosimilar since 2006 and is still waiting. Biocon acquired a company in Germany in 2008 to reach the market. Some global players like Novartis, Hospira and Teva have a head-start because they are marketing some products in developed markets.”

About the company objectives with the Biosimilar drug in the Europe, economictimes.indiatimes.com, writes, “The company also hopes to enter regenerative therapies for acute kidney injuries and wound management, he said. However, the biggest concern with stem cells is that so far it is not scalable.

Therefore mass, ready to use solutions are not available. At present, the original cell has to be taken from the patient, grown and then used. This is a lengthy and expensive process.”

Reliance Life’s Biosimilar drug in the Europe is the biggest news just like H1N1 Swine Flu Virus Vaccination in India. Reliance Life tries to cover the European country with its new and effective drug product.